Description

8-Bromo-6-Methylimidazo[1,2-A]Pyrazine is a high-purity, advanced pharmaceutical intermediate characterized by its fused heterocyclic structure. This compound is of significant commercial importance as a key building block in the synthesis of novel active pharmaceutical ingredients (APIs), particularly in therapeutic areas requiring complex molecular architectures. It is primarily utilized by research institutions and pharmaceutical manufacturers engaged in drug discovery and process development for oncology, antiviral, and central nervous system (CNS) applications.

Application

• Pharmaceutical Intermediate: A critical precursor in the multi-step synthesis of complex drug candidates, especially kinase inhibitors and other targeted therapies.
• Medicinal Chemistry Research: Serves as a versatile scaffold for structure-activity relationship (SAR) studies and lead optimization in drug discovery programs.
• Organic Synthesis Building Block: Used in cross-coupling reactions (e.g., Suzuki, Buchwald-Hartwig) to introduce the imidazopyrazine moiety into more complex molecules.
• Agrochemical Research: Potential application in the development of new herbicides or fungicides due to its heterocyclic bioactivity.
• Material Science Exploration: Investigated as a component in the synthesis of organic electronic materials and ligands for catalytic systems.

Basic Information

Product Name	8-Bromo-6-Methylimidazo[1,2-A]Pyrazine
CAS No.	1025976-69-5
Molecular Formula	C7H6BrN3
Molecular Weight	212.05 g/mol
Synonyms	8-Bromo-6-methylimidazo[1,2-a]pyrazine; 6-Methyl-8-bromoimidazo[1,2-a]pyrazine; Imidazo[1,2-a]pyrazine, 8-bromo-6-methyl-; 1025976-69-5; 8-Bromo-6-methyl-imidazo[1,2-a]pyrazine
EINECS	Contact for details

Quality Control

Our 8-Bromo-6-Methylimidazo[1,2-A]Pyrazine is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC for purity and identity confirmation via NMR and mass spectrometry, to ensure it meets the high standards required for pharmaceutical research. A comprehensive Certificate of Analysis (COA) detailing purity, impurities, and physical characteristics is provided with every shipment.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated place at a controlled room temperature (15-25°C). Keep the container tightly sealed in a dry environment to prevent moisture absorption.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (HPLC)	Conforms
Purity (HPLC)	≥ 98.0%
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 20 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.